Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients.
White
S A
SA
Department of Surgery, Leicester General Hospital, UK.
Bicknell
G R
GR
Jain
S
S
Williams
S T
ST
Doughman
T
T
Furness
P
P
Nicholson
M L
ML
D000208:Acute Disease; D000328:Adult; D003094:Collagen / Q000235:genetics; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005355:Fibrosis; D005786:Gene Expression Regulation / Q000276:immunology*; D006084:Graft Rejection / Q000235:genetics / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007678:Kidney Glomerulus / Q000473:pathology; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016559:Tacrolimus / Q000627:therapeutic use*; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000235:genetics; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000235:genetics; D014158:Transcription, Genetic; D016212:Transforming Growth Factor beta / Q000235:genetics
D007166:Immunosuppressive Agents; D019715:Tissue Inhibitor of Metalloproteinase-1; D016212:Transforming Growth Factor beta; D019716:Tissue Inhibitor of Metalloproteinase-2; D016572:Cyclosporine; D003094:Collagen; D020778:Matrix Metalloproteinase 2; D016559:Tacrolimus